What is the recommended workup for a slow‑healing wound?

Workup for Slow-Healing Wounds

Begin by assessing vascular status, infection, metabolic factors, and wound characteristics—then optimize standard care with sharp debridement, moisture-balancing dressings, and pressure off-loading before considering adjunctive therapies only after 2 weeks of failed standard treatment.

Initial Assessment Protocol

Vascular Evaluation

• Palpate pedal pulses and measure ankle-brachial index (ABI) in every slow-healing wound; if ABI < 0.9 or pulses are absent, obtain toe pressure or transcutaneous oxygen pressure (TcPO₂). 1
• Critical ischemia thresholds requiring urgent revascularization are toe pressure < 30 mmHg, ankle pressure < 50 mmHg, or TcPO₂ < 25 mmHg. 1
• An ABI < 0.6 severely compromises healing; revascularization (surgical bypass or endovascular therapy) should be considered before advanced wound therapies. 1

Infection Assessment

• Look for clinical signs of infection: purulence, erythema extending >2 cm from wound edge, warmth, tenderness, induration, fever, or leukocytosis. 2, 1
• Probe the wound to assess for exposed bone, tendon, or joint involvement. 1
• Obtain tissue specimens from the debrided wound base via curettage or biopsy—avoid swabbing undebrided ulcers. 1
• Initiate systemic antibiotics only when clinical infection is present; do not treat uninfected wounds with antimicrobials. 2, 1

Metabolic and Systemic Factors

• Check glycemic control (target blood glucose < 8 mmol/L or < 140 mg/dL), as hyperglycemia delays wound healing through osmotic diuresis, decreased oxygenation, and impaired neutrophil function. 3, 1
• Assess nutritional status, particularly protein and mineral deficiency, which can delay healing. 1, 4
• Evaluate for edema, which impairs tissue perfusion and healing. 1
• Screen for medications that impair healing: corticosteroids (prednisone ≥40 mg), immunosuppressants, and anticoagulants affecting platelet function. 5

Wound Characteristics

• Determine wound location: plantar weight-bearing surfaces suggest neuropathic etiology, while foot margins (heel, toe tips, lateral borders) suggest ischemic etiology. 1
• Measure wound dimensions and calculate area to track healing progress; < 50% area reduction after 2 weeks of standard care indicates need for adjunctive therapy. 2, 1

Standard Care Optimization (Must Be Implemented First)

Sharp Debridement

• Perform scalpel debridement at every visit to remove all necrotic tissue, slough, and surrounding callus—this is the only debridement method with strong evidence support. 2, 3, 1
• Frequency should be determined by clinical need based on wound appearance. 2, 3
• Do not use enzymatic, ultrasonic, autolytic, biosurgical, hydrosurgical, chemical, or laser debridement over standard sharp debridement. 2

Moisture-Balancing Dressings

• Apply simple moisture-absorbing dressings (gauze or non-adherent dressings) that maintain a moist wound environment, selected based on exudate level, comfort, and cost—not for antimicrobial properties. 2, 3, 1
• Clean wounds regularly with water or saline. 1

Pressure Off-Loading (for plantar ulcers)

• Use a non-removable knee-high off-loading device (total-contact cast or irremovable walker) as first-line therapy for neuropathic plantar forefoot or midfoot ulcers. 3, 1, 6
• If contraindicated or not tolerated, use a removable knee-high or ankle-high device with strict adherence counseling. 1, 6
• When no device is available, apply felted foam combined with appropriate footwear. 1, 6

Interventions to Avoid (Strong Evidence Against)

• Do not use topical antiseptic or antimicrobial dressings (including silver, iodine, honey, or bee products) for wound healing purposes. 2, 3, 1
• Do not use collagen or alginate dressings—9 of 12 trials showed no benefit. 2, 1
• Do not use topical phenytoin, herbal remedies, or physical therapy modalities (ultrasound, electrical stimulation). 2, 1
• Do not use pharmacological agents that supplement vitamins, trace elements, or stimulate red cell production over standard care. 2
• Do not use growth factor therapy or cellular/acellular skin substitutes as routine adjunct therapy. 2, 1

Adjunctive Therapies (Only After ≥2 Weeks of Failed Standard Care)

Conditional Recommendations (Moderate Certainty)

• Consider sucrose-octasulfate impregnated dressing for non-infected, neuro-ischemic ulcers with < 50% area reduction after 2 weeks of optimized standard care including appropriate off-loading. 2, 3, 1
• Consider autologous leucocyte, platelet, and fibrin patch where resources exist for regular venepuncture and standard care has been ineffective. 2, 3, 6

Conditional Recommendations (Low Certainty)

• Consider hyperbaric oxygen therapy for neuro-ischemic or ischemic ulcers where standard care has failed and resources exist. 3, 1, 6
• Consider topical oxygen therapy when standard care has failed and appropriate resources are available. 1
• Consider negative pressure wound therapy as adjunct for post-surgical wounds only—do not use for non-surgically related ulcers. 2, 6
• Consider placental-derived products as adjunct therapy where standard care alone has failed. 2

Reassessment Timeline

• Re-evaluate outpatients in 2–4 days, inpatients daily, and earlier if condition worsens. 1
• If no clinical improvement occurs within 6 weeks despite optimal management, revascularization should be considered regardless of bedside perfusion test results. 1
• Confirm adequate arterial perfusion, consider vascular surgery consultation, and rule out undiagnosed osteomyelitis with probe-to-bone test, MRI, or bone biopsy. 1

Common Pitfalls to Avoid

• Avoid footbaths, which cause skin maceration and impede healing. 1
• Do not delay revascularization in ischemic wounds—this markedly reduces healing likelihood regardless of wound care. 1
• Do not use removable off-loading devices without strict adherence counseling, as patients frequently remove them at home. 1
• Do not initiate adjunctive therapies before optimizing standard care for at least 2 weeks. 2, 1